TABLE OF CONTENT: Introduction Research Scope Market Segmentation Research Methodology Definitions and Assumptions Executive Summary Market Dynamics Market Drivers Market Restraints Market Opportunities Key Insights Prevalence of Lymphoma - by Key Countries - 2018 Pipeline Analysis Key Industry Developments Regulatory Scenario, by Key Regions Analysis of Economic Burden of Non-Hodgkin Lymphoma New Product Launches Overview of Emerging Treatments for Non-Hodgkin Lymphoma Global Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis, Insights and Forecast – By Therapy Immunotherapy Targeted Therapy Chemotherapy Others Market Analysis, Insights and Forecast – By Disease Type B-cell Lymphoma T-cell Lymphoma Market Analysis, Insights and Forecast – By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Market Analysis, Insights and Forecast – By Region North America Europe Asia Pacific Latin America Middle East & Africa North America Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis – By Therapy Immunotherapy Targeted Therapy Chemotherapy Others Market Analysis – By Disease Type B-cell Lymphoma T-cell Lymphoma Market Analysis – By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Market Analysis – By Country U.S. Canada Europe Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis – By Therapy Immunotherapy Targeted Therapy Chemotherapy Others Market Analysis – By Disease Type B-cell Lymphoma T-cell Lymphoma Market Analysis – By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Market Analysis – By Country/ sub-region U.K. Germany France Spain Italy Scandinavia Rest of Europe Asia Pacific Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis – By Therapy Immunotherapy Targeted Therapy Chemotherapy Others Market Analysis – By Disease Type B-cell Lymphoma T-cell Lymphoma Market Analysis – By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Market Analysis – By Country/ sub-region Japan China India Australia Southeast Asia Rest of Asia Pacific Latin America Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis – By Therapy Immunotherapy Targeted Therapy Chemotherapy Others Market Analysis – By Disease Type B-cell Lymphoma T-cell Lymphoma Market Analysis – By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Market Analysis – By Country/ sub-region Brazil Mexico Rest of Latin America Middle East & Africa Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026 Key Findings / Summary Market Analysis – By Therapy Immunotherapy Targeted Therapy Chemotherapy Others Market Analysis – By Disease Type B-cell Lymphoma T-cell Lymphoma Market Analysis – By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Market Analysis – By Country/ sub-region GCC Countries South Africa Rest of Middle East & Africa Competitive Analysis Key Industry Developments Global Market Share Analysis (2018) Competition Dashboard Comparative Analysis – Major Players Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) Takeda Pharmaceutical Company Limited Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) AstraZeneca Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Bayer AG Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Novartis AG Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Spectrum Pharmaceuticals, Inc. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Bristol Myers Squibb Company Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Janssen Pharmaceuticals, Inc. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Genentech, Inc. (F. Hoffmann-La Roche Ltd) Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Merck & Co., Inc. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Spectrum Pharmaceuticals, Inc. Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Other Prominent Players Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability) Strategic Recommendations

Takeda Pharmaceutical Company Limited AstraZeneca Bayer AG Novartis AG Kite Pharma, Inc. / Gilead Sciences, Inc. Spectrum Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd. Bristol Myers Squibb Company Janssen Pharmaceuticals, Inc. Genentech, Inc. (F. Hoffmann-La Roche Ltd) CELGENE CORPORATION (Bristol Myers Squibb Company) Merck & Co., Inc. Kyowa Kirin Co., Ltd. AbbVie Inc. Sanofi Others